| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |